PANDEL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pandel, and what generic alternatives are available?
Pandel is a drug marketed by Ani Pharms and is included in one NDA.
The generic ingredient in PANDEL is hydrocortisone probutate. There are sixty-seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the hydrocortisone probutate profile page.
Summary for PANDEL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 31 |
Clinical Trials: | 1 |
Patent Applications: | 1,118 |
Drug Prices: | Drug price information for PANDEL |
What excipients (inactive ingredients) are in PANDEL? | PANDEL excipients list |
DailyMed Link: | PANDEL at DailyMed |
Recent Clinical Trials for PANDEL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Fougera Pharmaceuticals Inc. | Phase 4 |
Pharmacology for PANDEL
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for PANDEL
US Patents and Regulatory Information for PANDEL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ani Pharms | PANDEL | hydrocortisone probutate | CREAM;TOPICAL | 020453-001 | Feb 28, 1997 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PANDEL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ani Pharms | PANDEL | hydrocortisone probutate | CREAM;TOPICAL | 020453-001 | Feb 28, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PANDEL
See the table below for patents covering PANDEL around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Italy | 1206453 | CREMA AVENTE UN'ECCELLENTE ATTIVITA' ANTI-INFIAMMATORIA. | ⤷ Try a Trial |
Japan | S59139315 | CREAM AGENT | ⤷ Try a Trial |
United Kingdom | 2135576 | HYDROCORTISONE BUTYRATE PROPIONATE CREAMS | ⤷ Try a Trial |
Austria | A31484 | ⤷ Try a Trial | |
South Africa | 8400527 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for PANDEL
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0809498 | SPC/GB10/012 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112 |
0809498 | 10C0038 | France | ⤷ Try a Trial | PRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |